This page in English

Yvonne Freund-Levi

Anknuten

Besöksadress : Novum Pl 5, Hälsovägen 7/Blickagången 6 141 57 Huddinge
Postadress : Institutionen för Neurobiologi, Vårdvetenskap och Samhälle (NVS), H1, Sektionen för klinisk geriatrik, Novum Pl 5, Blickagången 6/Hälsovägen 7 14157 Huddinge
Leveransadress : Novum Pl 5, Hiss G, Hälsovägen 7/Blickagången 6 141 57 Huddinge

Publikationer

Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study
Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-levi Y, Wahlund Lo, et al
Journal of lipid research 2015;56(3):674-81

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study
Eriksdotter M, Vedin I, Falahati F, Freund-levi Y, Hjorth E, Faxen-irving G, et al
Journal of Alzheimer's disease : JAD 2015;48(3):805-12

Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
Hall A, Mattila J, Koikkalainen J, Lojonen J, Wolz R, Scheltens P, et al
CURRENT ALZHEIMER RESEARCH 2015;12(1):69-79

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
Vos Sj, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, et al
Brain : a journal of neurology 2015;138(Pt 5):1327-38

Agitation in dementia: relation to core cerebrospinal fluid biomarker levels
Bloniecki V, Aarsland D, Cummings J, Blennow K, Freund-levi Y
Dementia and geriatric cognitive disorders extra 2014;4(2):335-43

Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study
Freund-levi Y, Vedin I, Hjorth E, Basun H, Faxén Irving G, Schultzberg M, et al
Journal of Alzheimer's disease : JAD 2014;42(3):823-31

Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study
Freund-levi Y, Bloniecki V, Auestad B, Tysen Bäckström Ac, Lärksäter M, Aarsland D
Dementia and geriatric cognitive disorders 2014;38(3-4):234-44

Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial
Freund-levi Y, Jedenius E, Tysen-bäckström Ac, Lärksäter M, Wahlund Lo, Eriksdotter M
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2014;22(4):341-8

Neuropsychiatric symptoms in dementia-a role for neuroinflammation?
Holmgren S, Hjorth E, Schultzberg M, Lärksäter M, Frenkel D, Tysen-bäckström Ac, et al
Brain research bulletin 2014;108():88-93

Response to Bogaiksy's letter to the editor
Freund-levi Y, Jedenius E, Wahlund Lo, Eriksdotter M, Tysen-bäckström Ac, Lärksäter M
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2014;22(9):951-

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
Levi Yf, Vedin I, Cederholm T, Basun H, Irving Gf, Eriksdotter M, et al
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE 2014;231(3):428-436

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxén Irving G, Eriksdotter M, et al
Journal of internal medicine 2014;275(4):428-36

Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study
Faxén-irving G, Freund-levi Y, Eriksdotter-jönhagen M, Basun H, Hjorth E, Palmblad J, et al
Journal of Alzheimer's disease : JAD 2013;36(1):1-6

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients
Forsberg A, Juréus A, Cselényi Z, Eriksdotter M, Freund-levi Y, Jeppsson F, et al
European journal of nuclear medicine and molecular imaging 2013;40(4):580-93

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers
Hjorth E, Zhu M, Toro Vc, Vedin I, Palmblad J, Cederholm T, et al
Journal of Alzheimer's disease : JAD 2013;35(4):697-713

Agitation - relation to clinical and dementia biomarkers in cerebrospinal fluid
Bloniecki V, Freund-levi Y, Aarsland D, Blennow K
EUROPEAN JOURNAL OF NEUROLOGY 2012;:112-112

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study
Vedin I, Cederholm T, Freund-levi Y, Basun H, Garlind A, Irving Gf, et al
PloS one 2012;7(4):e35425-

Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid
Hjorth E, Freund-levi Y
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE 2012;15(2):134-43

Reduced prostaglandin F-2 alpha release from blood mononuclear leukocytes after oral supplementation of omega 3 fatty acids: the OmegAD study
Vedin I, Cederholm T, Freund-levi Y, Basun H, Hjorth E, Irving Gf, et al
JOURNAL OF LIPID RESEARCH 2010;51(5):1179-85

To Be a Good Food Provider: An Exploratory Study Among Spouses of Persons With Alzheimer's Disease
Omegad Study Grp, Fjellstrom C, Starkenberg A, Wesslen A, Licentiate Ms, Backstrom Act, et al
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS 2010;25(6):521-6

Detection of amyloid in Alzheimer's disease with positron emission tomography using [C-11]AZD2184
Nyberg S, Jonhagen Me, Cselenyi Z, Halldin C, Julin P, Olsson H, et al
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2009;36(11):1859-63

Effects of Omega-3 Fatty Acids on Inflammatory Markers in Cerebrospinal Fluid and Plasma in Alzheimer's Disease: The OmegAD Study
Freund-levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-irving G, Vedin I, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2009;27(5):481-90

Omega-3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega-3 Alzheimer's Disease Study
Irving Gf, Freund-levi Y, Eriksdotter-joenhagen M, Basun H, Brismar K, Hjorth E, et al
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 2009;57(1):11-7

Omega Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega-3 Alzheimer's Disease Study (vol 57, pg 11, 2009)
Irving Gf, Freund-levi Y
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 2009;57(3):579-579

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Visser Pj, Verhey F, Knol Dl, Scheltens P, Wahlund Lo, Freund-levi Y, et al
LANCET NEUROLOGY 2009;8(7):619-27

Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
Vedin I, Cederholm T, Levi Yf, Basun H, Garlind A, Irving Gf, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2008;87(6):1616-22

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
Freund-levi Y, Basun H, Cederholm T, Faxen-irving G, Garlind A, Grut M, et al
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 2008;23(2):161-9

[Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited]
Palmblad J, Eriksdotter-jönhagen M, Freund-levi Y, Cederholm T
Lakartidningen 2007;104(44):3268-71

[Administration of symptom-relieving drugs in Alzheimer disease is beneficial]
Nordberg A, Eriksdotter-jönhagen M, Garlind A, Grut M, Freund-levi Y, Cornelius C, et al
Lakartidningen 2006;103(6):369-71

omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study - A randomized double-blind trial
Freund-levi Y, Eriksdotter-jonhagen M, Cederholm T, Basun H, Faxen-irving G, Garlind A, et al
ARCHIVES OF NEUROLOGY 2006;63(10):1402-8

Inflammatory gene expression changes by omega-3 fatty acids in patients with Alzheimer's disease
Omegad Study Grp, Vedin I, Cederholm T, Liden J, Freund-levi Y, Palmblad J
FASEB JOURNAL 2004;18(4):A501-A501

Safety and tolerability of omega-3 fatty acids in patients with Alzheimers disease
Freund-levi Y, Jonhagen Me, Wahlund Lo, Basun H, Palmblad J, Cederholm T
NEUROBIOLOGY OF AGING 2004;:S471-S471

Visa alla publikationer